Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)

scientific article published on 08 February 2020

Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10120-020-01043-X
P698PubMed publication ID32036492

P50authorNarikazu BokuQ88572199
Takako Eguchi NakajimaQ89612707
Ichinosuke HyodoQ118121981
P2093author name stringShinichiro Nakamura
Takeshi Sakamoto
Kohei Shitara
Tomohiro Nishina
Hiroshi Katayama
Kei Muro
Katsunori Shinozaki
Kensei Yamaguchi
Junki Mizusawa
Masanori Terashima
Hiroki Hara
P921main subjectpaclitaxelQ423762
peritoneal carcinomatosisQ2071182
P577publication date2020-02-08
P1433published inGastric CancerQ15724608
P1476titleRandomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)

Search more.